ICMH
AEON.WS

Integrity Capital Management (HK)’s AEON Biopharma Inc AEON.WS Stock Holding History

Integrity Capital Management (HK)’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-69,514
Closed -$35K – 255
2021
Q4 		$35K Buy
+69,514
New +$38.4K 0.11% 190

Other funds holding AEON.WS

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Integrity Capital Management (HK)'s AEON.WS Position: Q1 2022 in Review

Integrity Capital Management (HK) sold out of AEON Biopharma Inc (AEON.WS) in Q1 2022, closing a stake of 69,514 shares — an estimated $35K sold.

Integrity Capital Management (HK) first reported a position in AEON.WS in Q4 2021 and held it in 1 quarter. The position peaked at $35K in Q4 2021. 50 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2022.

  • Integrity Capital Management (HK) reported no remaining AEON Biopharma Inc position as of Q1 2022 after selling out during the quarter.
  • Integrity Capital Management (HK) sold 69,514 AEON Biopharma Inc shares in Q1 2022, an estimated $35K.
  • Integrity Capital Management (HK) first reported a position in AEON Biopharma Inc in Q4 2021 and held it in 1 quarter.
  • Integrity Capital Management (HK)'s AEON Biopharma Inc position peaked at $35K in Q4 2021.
  • 50 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2022.

Based on Integrity Capital Management (HK)'s 13F filing for Q1 2022, filed 26 Apr 2022.